Abbott India said that it has signed a non-exclusive patent license agreement with Takeda Pharmaceuticals Company to commercialize Vonoprazan, a novel molecule in the gastrointestinal therapy area, ...

The gold standard for diagnosing gastroesophageal reflux disease (GERD) is impedance-pH monitoring. This test is particularly ...

Caroline Cobine, Ph.D., an associate professor in the Department of Physiology and Cell Biology within the University of ...

Approximately 600 times a day, the esophagus ferries whatever is in your mouth down to your stomach. It's usually a one-way ...

The following is a summary of “Gastrointestinal dysmotility is associated with proton pump inhibitor refractory esophagitis in patients with systemic sclerosis,” published in the September 2024 issue ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

People with a history of upper gastrointestinal (GI) damage have a 76% higher risk of developing Parkinson’s disease.

Over a mean follow-up of 14.9 years, Parkinson's diagnoses emerged for 52 patients (2.2%) with upper GI mucosal damage and 48 ...

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson's disease ...